Asfour, F.
121  Ergebnisse:
Personensuche X
?
 
?
 
?
 
?
4

415 Transition process: improving the experience for PwCF, ..:

Meihls, S. ; Asfour, F. ; Burbidge, K....
Journal of Cystic Fibrosis.  22 (2023)  - p. S215-S216 , 2023
 
?
5

P185 Prospective randomized observational study validating ..:

Liou, T.G. ; Argel, N. ; Asfour, F....
Journal of Cystic Fibrosis.  22 (2023)  - p. S121-S122 , 2023
 
?
 
?
 
?
8

138 Defining and identifying early-onset lung disease in cy..:

Huang, L. ; Lai, H. ; Antos, N....
Journal of Cystic Fibrosis.  21 (2022)  - p. S81-S82 , 2022
 
?
 
?
10

555 Effectiveness of a dedicated Pseuodomonas aeruginosa er..:

Tempest, A. ; Zobell, J. ; Olson, J....
Journal of Cystic Fibrosis.  21 (2022)  - p. S308-S309 , 2022
 
?
11

262 Implementation of a comprehensive pharmacy-driven immun..:

Zobell, J. ; Moss, J. ; Jensen, B....
Journal of Cystic Fibrosis.  21 (2022)  - p. S154-S155 , 2022
 
?
12

81 Results from the National Cystic Fibrosis Foundation Exp..:

Bailey, J. ; Gamory, D. ; Asfour, F...
Journal of Cystic Fibrosis.  21 (2022)  - p. S50-S51 , 2022
 
?
 
?
14

234: Beyond PFTs: Elexacaftor/tezacaftor/ivacaftor outcomes..:

Zobell, J. ; Hill, M. ; Grady, A....
Journal of Cystic Fibrosis.  20 (2021)  - p. S113-S114 , 2021
 
?
 
1-15